Literature DB >> 22728116

Goodbye androgen hypothesis, hello saturation model.

Abraham Morgentaler.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22728116     DOI: 10.1016/j.eururo.2012.06.027

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  8 in total

Review 1.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

2.  Words of wisdom. Re: Testosterone treatment is a potent tumor promoter for the rat prostate.

Authors:  Jason M Scovell; Peter Butler; Ranjith Ramasamy; Dolores J Lamb
Journal:  Eur Urol       Date:  2015-04       Impact factor: 20.096

Review 3.  The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression.

Authors:  Abdulmaged M Traish; Ashwini Mulgaonkar; Nicholas Giordano
Journal:  Korean J Urol       Date:  2014-06-16

4.  Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.

Authors:  A M Traish; A Haider; G Doros; F Saad
Journal:  Int J Clin Pract       Date:  2013-10-15       Impact factor: 2.503

Review 5.  Testosterone deficiency and cardiovascular mortality.

Authors:  Abraham Morgentaler
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

6.  Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss.

Authors:  Aa Yassin; G Doros
Journal:  Clin Obes       Date:  2013-06-19

Review 7.  Testosterone and weight loss: the evidence.

Authors:  Abdulmaged M Traish
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

8.  Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.

Authors:  F Saad; A Yassin; G Doros; A Haider
Journal:  Int J Obes (Lond)       Date:  2015-07-29       Impact factor: 5.095

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.